Albert G. White III Sells 114,992 Shares of The Cooper Companies, Inc. (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Cooper Companies Trading Down 0.5 %

Shares of Cooper Companies stock traded down $0.61 on Friday, hitting $110.49. 1,914,533 shares of the company’s stock traded hands, compared to its average volume of 1,125,396. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The company has a fifty day moving average of $97.54 and a two-hundred day moving average of $95.48. The company has a market capitalization of $22.00 billion, a price-to-earnings ratio of 64.79, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the prior year, the company earned $0.84 EPS. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.66 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. Robert W. Baird upped their target price on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley upped their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $115.00.

Institutional Investors Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently made changes to their positions in the business. Brown Advisory Inc. bought a new position in Cooper Companies in the fourth quarter worth approximately $243,000. ING Groep NV boosted its holdings in Cooper Companies by 3,766.7% in the fourth quarter. ING Groep NV now owns 580 shares of the medical device company’s stock worth $220,000 after acquiring an additional 565 shares in the last quarter. Norges Bank bought a new position in Cooper Companies in the fourth quarter worth approximately $196,045,000. BI Asset Management Fondsmaeglerselskab A S boosted its holdings in Cooper Companies by 34.4% in the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 2,322 shares of the medical device company’s stock worth $879,000 after acquiring an additional 594 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in Cooper Companies by 1.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 21,385 shares of the medical device company’s stock worth $8,093,000 after acquiring an additional 346 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.